Melanotan II for Fat Loss
Research, mechanism, dosing, and effectiveness of Melanotan II for fat loss.
Quick Answer
MT-II may reduce appetite and support fat loss as a secondary effect.
Evidence Level
Limited Research
Typical Dose
0.5-1 mg daily
Results Timeline
Fat loss over 4-8 weeks
FDA Status
Research Only
How Melanotan II Works for Fat Loss
Melanocortin activation reduces appetite through central mechanisms.
About Fat Loss
Reduction of body fat while preserving lean muscle mass.
Research Evidence
Research demonstrates effective skin darkening without UV exposure, though UV enhances effects. Studies show improvement in erectile dysfunction. Originally developed for skin cancer prevention. PT-141 (bremelanotide) was derived from this research.
Dosing for Fat Loss
Recommended Dose
0.5-1 mg daily
Frequency
Daily during loading (1-2 weeks), then weekly maintenance
Administration
Subcutaneous injection
Duration
Loading phase 2-3 weeks, then maintenance
Note: Start very low to assess tolerance. Causes tanning, may increase libido. Nausea common initially. UV exposure needed for tanning effect.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Nausea (common)
- •Facial flushing
- •Fatigue
- •Spontaneous penile erections
- •Darkening of skin and moles
- •Priapism (requires emergency care)
Frequently Asked Questions
Does Melanotan II help with fat loss?
MT-II may reduce appetite and support fat loss as a secondary effect.
How does Melanotan II work for fat loss?
Melanocortin activation reduces appetite through central mechanisms....
What dose of Melanotan II should I use for fat loss?
0.5-1 mg daily
How long until I see results?
Fat loss over 4-8 weeks
Other Peptides for Fat Loss
These peptides are also researched for fat loss.
PT-141
FDAAn FDA-approved melanocortin receptor agonist for treating hypoactive sexual desire disorder (HSDD) in premenopausal women. Derived from Melanotan II research.
BPC-157
PreclinicalA synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems. FDA classified as Category 2 in 2023, restricting compounding.
TB-500
PreclinicalA synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). Unlike TB-4, TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.
Semaglutide
FDAA GLP-1 receptor agonist with multiple FDA approvals including weight loss, T2D, CV risk reduction, and kidney protection. Wegovy pill approved Dec 2025 as first oral GLP-1 for weight loss.
Educational Information Only
This information about Melanotan II for fat loss is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.